Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Clinical Pharmacology and Therapeutics
|
October 15, 2019
Exposure-Response Analyses of Upadacitinib Efficacy and Safety in Phase II and III Studies to Support Benefit-Risk Assessment in Rheumatoid Arthritis
Ahmed Nader, Mohamed-Eslam F Mohamed, Insa Winzenborg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 28, 2016
Frequency of Axial Spondyloarthritis Diagnosis Among Patients Seen by US Rheumatologists for Evaluation of Chronic Back Pain
Atul Deodhar, Philip J Mease, John D Reveille, et al.
The Journal of Rheumatology
|
October 5, 2010
Disease activity, physical function, and radiographic progression after longterm therapy with adalimumab plus methotrexate: 5-year results of PREMIER
Désirée van der Heijde, Ferdinand C Breedveld, Arthur Kavanaugh, et al.
Arthritis Care & Research
|
February 22, 2011
Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry
Daniel E Furst, Aileen L Pangan, Leslie R Harrold, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2011
Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis?
Katherine Gooch, David Feeny, Robert L Wong, et al.
Annals of the Rheumatic Diseases
|
August 7, 2015
A psychometric analysis of outcome measures in peripheral spondyloarthritis
Maureen C Turina, Sofia Ramiro, Dominique L Baeten, et al.
Arthritis Research & Therapy
|
January 7, 2021
Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE)
Hideto Kameda, Tsutomu Takeuchi, Kunihiro Yamaoka, et al.
The New England Journal of Medicine
|
October 14, 2020
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
Andrea Rubbert-Roth, Jeffrey Enejosa, Aileen L Pangan, et al.
Arthritis Care & Research
|
July 31, 2015
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis
Rubén Burgos-Vargas, Shirley M L Tse, Gerd Horneff, et al.
RMD Open
|
March 14, 2018
Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2
Filip Van den Bosch, Philip J Mease, Joachim Sieper, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Clinical Pharmacology and Therapeutics
|
October 15, 2019
Exposure-Response Analyses of Upadacitinib Efficacy and Safety in Phase II and III Studies to Support Benefit-Risk Assessment in Rheumatoid Arthritis
Ahmed Nader, Mohamed-Eslam F Mohamed, Insa Winzenborg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 28, 2016
Frequency of Axial Spondyloarthritis Diagnosis Among Patients Seen by US Rheumatologists for Evaluation of Chronic Back Pain
Atul Deodhar, Philip J Mease, John D Reveille, et al.
The Journal of Rheumatology
|
October 5, 2010
Disease activity, physical function, and radiographic progression after longterm therapy with adalimumab plus methotrexate: 5-year results of PREMIER
Désirée van der Heijde, Ferdinand C Breedveld, Arthur Kavanaugh, et al.
Arthritis Care & Research
|
February 22, 2011
Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry
Daniel E Furst, Aileen L Pangan, Leslie R Harrold, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2011
Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis?
Katherine Gooch, David Feeny, Robert L Wong, et al.
Annals of the Rheumatic Diseases
|
August 7, 2015
A psychometric analysis of outcome measures in peripheral spondyloarthritis
Maureen C Turina, Sofia Ramiro, Dominique L Baeten, et al.
Arthritis Research & Therapy
|
January 7, 2021
Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE)
Hideto Kameda, Tsutomu Takeuchi, Kunihiro Yamaoka, et al.
The New England Journal of Medicine
|
October 14, 2020
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
Andrea Rubbert-Roth, Jeffrey Enejosa, Aileen L Pangan, et al.
Arthritis Care & Research
|
July 31, 2015
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis
Rubén Burgos-Vargas, Shirley M L Tse, Gerd Horneff, et al.
RMD Open
|
March 14, 2018
Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2
Filip Van den Bosch, Philip J Mease, Joachim Sieper, et al.
Page
of 5